You have 9 free searches left this month | for more free features.

neoadjuvant PD-L1 blockade

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Relapsed or Refractory Multiple Myeloma Trial (Vorinostat, Bortezomib, Dexamethasone)

Completed
  • Relapsed or Refractory Multiple Myeloma
  • (no location specified)
Mar 5, 2021

Renal Cell Carcinoma Trial in Worldwide (Lenvatinib, Everolimus, Pembrolizumab)

Active, not recruiting
  • Renal Cell Carcinoma
  • Stanford, California
  • +182 more
Jul 1, 2022

Physical Exercise Intervention in Breast Cancer Patients at Risk

Recruiting
  • Breast Cancer
    • Aberdeen, Aberdeenshire, United Kingdom
      Cardiovascular Research Facility
    Sep 29, 2021

    Coronavirus, Respiratory Failure, Coronavirus Sars-Associated as Cause of Disease Classified Elsewhere Trial (Angiotensin 1-7,

    Not yet recruiting
    • Coronavirus
    • +3 more
    • Angiotensin 1-7
    • Placebos
    • (no location specified)
    Jul 30, 2021

    Physiological Effects of Drugs, Tumors by Histologic Type, Lymphoma Trial in Shanghai (SHR-1603)

    Suspended
    • Physiological Effects of Drugs
    • +5 more
    • Shanghai, Shanghai, China
      Shanghai East Hospital
    Mar 18, 2021

    Loneliness, Social Isolation Trial in Abbiategrasso (Facebook course, Lifestyle Course)

    Completed
    • Loneliness
    • Social Isolation
    • Facebook course
    • Lifestyle Course
    • Abbiategrasso, Milano, Italy
      Fondazione Golgi Cenci
    Apr 28, 2022

    Neuralized1 and RGS14 Genes

    Completed
    • Autism Spectrum Disorder
    • +2 more
    • Neurl1 gene expression
    • RGS14 gene expression
    • (no location specified)
    Jul 22, 2022

    Oropharyngeal Carcinoma, Immune Checkpoint Inhibitor, De-escalation Trial in Shanghai (Toxicities reduced treatment arm)

    Recruiting
    • Oropharyngeal Carcinoma
    • +2 more
    • Toxicities reduced treatment arm
    • Shanghai, China
      Fudan Universtiy Shanghai Cancer Centre
    Apr 27, 2021

    Covid-19 Trial in Nigeria (Antioxidation Therapy, Standard of Care)

    Withdrawn
    • Covid-19
    • Antioxidation Therapy
    • Standard of Care
    • Umuahia, Abia State, Nigeria
    • +10 more
    Oct 29, 2021

    Metabolic Syndrome Trial in University Park (Yogurt smoothie with BB-12, Yogurt smoothie)

    Recruiting
    • Metabolic Syndrome
    • Yogurt smoothie with BB-12
    • Yogurt smoothie
    • University Park, Pennsylvania
      The Pennsylvania State University
    Dec 12, 2021

    ARDS, Acute Respiratory Distress Syndrome, Intensive Care Unit Trial in Grenoble (Patients will receive MV in PP)

    Recruiting
    • ARDS
    • +3 more
    • Patients will receive MV in PP
    • Grenoble, France
      Grenoble University Hospital
    Oct 5, 2021

    Schizophrenia Negative Type Trial in Tianjin (tDCS active stimulation combined with rTMS sham stimulation, rTMS active

    Enrolling by invitation
    • Schizophrenia Negative Type
    • tDCS active stimulation combined with rTMS sham stimulation
    • +3 more
    • Tianjin, Tianjin, China
      Jie Li
    Jan 14, 2023

    Cognitive Change, Mood Trial in Orlando (PeakATP, Placebo)

    Completed
    • Cognitive Change
    • Mood
    • PeakATP
    • Placebo
    • Orlando, Florida
      Kinesiology Research Labs
    Aug 4, 2022

    Multiple Myeloma Trial in Worldwide (Dara SC, Dara IV)

    Active, not recruiting
    • Multiple Myeloma
    • Dara SC
    • Dara IV
    • Boston, Massachusetts
    • +145 more
    Jan 17, 2023

    Prostate Cancer Trial in Vancouver (buserelin, custirsen sodium, flutamide)

    Completed
    • Prostate Cancer
    • Vancouver, British Columbia, Canada
      British Columbia Cancer Agency - Vancouver Cancer Centre
    Apr 6, 2020

    Type 1 Diabetes Trial in Worldwide (Insulin glargine,300 U/mL, Insulin glargine (100 units /mL), Background therapy)

    Completed
    • Type 1 Diabetes Mellitus
    • Insulin glargine,300 U/mL
    • +2 more
    • Tucson, Arizona
    • +106 more
    Mar 15, 2022

    Essential Thrombocythemia, Primary Myelofibrosis, Fibrotic Stage, Primary Myelofibrosis, Prefibrotic Stage Trial in Doha

    Terminated
    • Essential Thrombocythemia
    • +3 more
    • Diagnostic (18F-FLT PET/CT)
    • Doha, Qatar
      National Center for Cancer Care & Research (NCCCR)
    Aug 10, 2020

    Advanced/Metastatic Solid Tumors Trial in Worldwide (Selicrelumab, Vanucizumab, Bevacizumab)

    Completed
    • Advanced/Metastatic Solid Tumors
    • Los Angeles, California
    • +15 more
    Apr 3, 2020

    Ovarian Cancer, Head Neck Cancer, Non Small Cell Lung Cancer Trial in United States (TJ004309)

    Recruiting
    • Ovarian Cancer
    • +5 more
    • Tucson, Arizona
    • +17 more
    Jan 18, 2022

    Inpatient Pulmonary Rehabilitation on Frailty in Patients After

    Completed
    • Advanced Lung Disease
    • +2 more
      • Schönau Am Königssee, Germany
        Schön Klinik Berchtesgadener Land
      Nov 4, 2021

      Sleep Disturbance Trial in Ostrava (Sleep protocol)

      Recruiting
      • Sleep Disturbance
      • Sleep protocol
      • Ostrava, Česká Republika, Czechia
        University of Ostrava
      May 30, 2022

      Rheumatoid Arthritis Trial in Ubbergen, Amsterdam (Adalimumab trough concentration, Usual care)

      Recruiting
      • Rheumatoid Arthritis
      • Adalimumab trough concentration
      • Usual care
      • Ubbergen, Gelderland, Netherlands
      • +1 more
      Jun 8, 2021

      SARS-CoV-2 PANDEMIC AND FAILED SPINAL ANESTHESIA

      Completed
      • Regional Anesthesia
      • SARS-CoV2 Infection
      • covid 19 spinal anesthesia
      • Ankara, Type A Choice Below ..., Turkey
        Aygun Guler
      Oct 18, 2021

      Carcinoma, Non-Small-Cell Lung Trial in Worldwide (Savolitinib, Osimertinib, Pemetrexed)

      Not yet recruiting
      • Carcinoma
      • Non-Small-Cell Lung
      • Orange City, Florida
      • +78 more
      Jul 20, 2022

      Advanced Soft Tissue Sarcoma Trial in Italy (Standard arm: Trabectedin in monotherapy, Experimental arm: Trabectedin + Olaparib)

      Recruiting
      • Advanced Soft Tissue Sarcoma
      • Standard arm: Trabectedin in monotherapy
      • Experimental arm: Trabectedin + Olaparib
      • Bologna, BO, Italy
      • +13 more
      Oct 29, 2021